scPharmaceuticals

• NCT05528588

  Collaborator, Phase 2, Completed, 70 people, 6 Sept 2022

• NCT04161482

  Phase 1, Completed, 39 people, 13 Nov 2019

• NCT02721511

  Collaborator, Phase 1/2, Withdrawn, 0 people, 29 Mar 2016

• NCT02579057

  Collaborator, Phase 2/3, Completed, 40 people, 19 Oct 2015

• NCT02350725

  Phase 1/2, Completed, 10 people, 30 Jan 2015

• NCT02329834

  Phase 2/3, Completed, 23 people, 1 Jan 2015

• Burden of chronic kidney disease and outcomes following hospitalisation for heart failure

  Consulting or advice, Board or leadership role, 25 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov